Precede Biosciences

Precede Biosciences

Biotechnology, 238 Main St, Boston, Massachusetts, 02142, United States, 11-50 Employees

precede.bio

  • LinkedIn

phone no Phone Number: +15*********

Who is PRECEDE BIOSCIENCES

We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address t...

Read More

map
  • 238 Main St, Boston, Massachusetts, 02142, United States Headquarters: 238 Main St, Boston, Massachusetts, 02142, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PRECEDE BIOSCIENCES

Precede Biosciences Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Precede Biosciences

Answer: Precede Biosciences's headquarters are located at 238 Main St, Boston, Massachusetts, 02142, United States

Answer: Precede Biosciences's phone number is +15*********

Answer: Precede Biosciences's official website is https://precede.bio

Answer: Precede Biosciences's revenue is $100 Million to $250 Million

Answer: Precede Biosciences's SIC: 8731

Answer: Precede Biosciences's NAICS: 541714

Answer: Precede Biosciences has 11-50 employees

Answer: Precede Biosciences is in Biotechnology

Answer: Precede Biosciences contact info: Phone number: +15********* Website: https://precede.bio

Answer: We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test uncovers actionable disease-defining transcriptional biology. Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual genes and pathways in diseased tissues from just 1mL of plasma. By partnering with developers of new medicines and advancing our own diagnostic tests, were working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment thats precise to the biology of their disease.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access